Moreover, inhibiting miR-205-5p reversed HCC resistance to 5-fluorouracil (5-FU) by regulating the PTEN/JNK/ANXA3 (phosphatase and tensin homolog/Janus kinase/annexin A3) pathway 13. The gene discussed is ANXA3; the disease is hepatocellular carcinoma.